Log in to save to my catalogue

Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer...

Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_163a6e71916643148e155085757324ce

Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients

About this item

Full title

Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients

Publisher

Los Angeles, CA: SAGE Publications

Journal title

Cancer control, 2023-11, Vol.30, p.10732748221141672-10732748221141672

Language

English

Formats

Publication information

Publisher

Los Angeles, CA: SAGE Publications

More information

Scope and Contents

Contents

Purpose
We aimed to identify the differently expressed genes or related pathways associated with good responses to anti-HER2 therapy and to suggest a model for predicting drug response in neoadjuvant systemic therapy with trastuzumab in HER2-positive breast cancer patients.
Methods
This study was retrospectively analyzed from consecutively...

Alternative Titles

Full title

Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_163a6e71916643148e155085757324ce

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_163a6e71916643148e155085757324ce

Other Identifiers

ISSN

1073-2748

E-ISSN

1526-2359

DOI

10.1177/10732748221141672

How to access this item